Revolution Medicines Inc. (NASDAQ: RVMD) Holds Above Offer Price, a Month After IPO, Despite...

Revolution Medicines Inc. (NASDAQ: RVMD) has held above its IPO price despite the market volatility.  A month ago, the stock went public at an offer...

New Issue/IPO: Arcutis Biotherapeutics (NASDAQ: ARQT) Makes New Highs After Hiring New VP

Arcutis Biotherapeutics Inc (NASDAQ: ARQT) made a new high in yesterday’s trading session. This came just a day after the company announced that Heather Rowe...

FANGDD Network Group Ltd (NASDAQ: DUO) Finds Support At Its IPO Price, After Weeks...

FANGDD Network Group Ltd (NASDAQ: DUO) is now trading at its IPO price after several weeks of sustained losses. The company which went public in...

LMP Automotive Holdings Inc (NASDAQ: LMPX) Up By 700% Since IPO, And Gaining

LMP Automotive Holdings Inc (NASDAQ: LMPX) has been one of the best-performing IPOs in the past two months. The stock went public on the 5th...

Bill.com Holdings Inc (NYSE: BILL) Sustains Rally Weeks After IPO – Initial Public Offering

Bill.com Holdings Inc (NYSE: BILL) went public in early December 2019, and so far it has performed well.  The stock went public at $22 and...

Galera Therapeutics Inc (NASDAQ: GRTX) Bounces Back to IPO Price Levels

Galera Therapeutics Inc (NASDAQ: GRTX) is now trading above its IPO price after a crash immediately after going public. The stock went public at an...

New Issue, 89bio Inc (NASDAQ: ETNB), Holds On To Gains a Month After IPO

89bio Inc (NASDAQ: ETNB) has been in consolidation for the better part of December. Nonetheless, it is still in gains compared to its IPO price....

Oyster Point Pharma (NASDAQ: OYST) Sustains Value Growth 2 Months after IPO

Oyster Point Pharma Inc (NASDAQ: OYST) has been one of the top performers since it went public in October.  The company went public at $16,...

Progyny Inc (NASDAQ: PGNY) Sustains Rally Weeks After Strong Q3 Results Post-IPO

Progyny Inc (NASDAQ: PGNY) has been one of the best performing, of the more recent IPOs. The company went public in October at a price...

Viela Bio Inc (NASDAQ: VIE) Makes Key Progress in Phase 2b Trial For VIB4920

Viela Bio Inc (NASDAQ: VIE) has been on an upside trajectory since it went public in October. The company went public at an offer price...

Must Read